Amicus Therapeutics Presents New Long-Term Data For Both Galafold® (Migalastat) And POMBILITI® (Cipaglucosidase Alfa-Atga) + OPFOLDA® (Miglustat) At The 22Nd Annual Worldsymposiumtm 2026

(MENAFN – GlobeNewsWire – Nasdaq) PRINCETON, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), today announced the presentation of new data from clinical and real-world …

Source: NewsData


Read Original Article

Leave a Comment